Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Diagnosing platform for neurological and mental disorders based on the analysis of ocular and oculocephalic movements.

Objective

The first product that AURA will launch to the market will be OSCANN, a diagnosis platform that will allow better, faster
and more accurate diagnosis of neurological disorders affecting Europe’s population in general, but specially youngsters
(e.g. ADHD) and elders (e.g. Parkinson). OSCANN allows for the measurement and analysis of ocular and oculocephalic
movements (OM/OCM) and combines the result with data obtained from other sources (clinical histories, medical
explorations, complementary tests and biomarkers) using Artificial Intelligence (AI) techniques to improve significantly the
quality of medical diagnosis in early stages.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-SMEInst-2016-2017

See all projects funded under this call

Coordinator

AURA INNOVATIVE ROBOTICS, SL
Net EU contribution
€ 50 000,00
Address
CALLE YARUMAL 2 1 A
28045 MADRID
Spain
SME
Yes
Region
Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00